Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - FIBROGEN INC | fgen-ex321_13.htm |
| EX-31.2 - EX-31.2 - FIBROGEN INC | fgen-ex312_9.htm |
| EX-31.1 - EX-31.1 - FIBROGEN INC | fgen-ex311_14.htm |
| EX-21.1 - EX-21.1 - FIBROGEN INC | fgen-ex211_241.htm |
| EX-10.44 - EX-10.44 - FIBROGEN INC | fgen-ex1044_204.htm |
| EX-10.36 - EX-10.36 - FIBROGEN INC | fgen-ex1036_605.htm |
| EX-10.35 - EX-10.35 - FIBROGEN INC | fgen-ex1035_604.htm |
| 10-K - 10-K - FIBROGEN INC | fgen-10k_20201231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-236844) and Form S-8 (No. 333-200348, No. 333-213816, No. 333-216369, and No. 333-233204) of FibroGen Inc. of our report dated March 1, 2021 relating to the financial statements and financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 1, 2021